Clinical Research Directory
Browse clinical research sites, groups, and studies.
Hydrogen's Feasibility and Safety as a Therapy in ECPR
Sponsor: Boston Children's Hospital
Summary
The purpose of this project is to test the feasibility and safety of inhaled hydrogen gas (H2) administration as a rescue therapy during cardiac arrest requiring extracorporeal cardiopulmonary resuscitation (ECPR, i.e. mechanical circulatory support). Under exemption from informed consent, patients undergoing refractory cardiac arrest in the cardiac ICU at a participating center will be randomized to standard therapy with or without the administration of 2% hydrogen in gases administered via the ventilator and ECMO membrane for 72 hours.
Official title: Hydrogen's Feasibility and Safety as a Therapy in Extracorporeal Cardiopulmonary Resuscitation
Key Details
Gender
All
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
53
Start Date
2024-03-04
Completion Date
2027-08-31
Last Updated
2025-07-03
Healthy Volunteers
No
Interventions
Hydrogen
Hydrogen gas (2%) in air or oxygen administered for 72 hours via ventilator and ECMO membrane. Oxygen concentration titrated per clinical team.
Usual care
Usual care post-ECPR event, including targeted temperature management.
Locations (4)
Children's National Hospital
Washington D.C., District of Columbia, United States
Boston Children's Hospital
Boston, Massachusetts, United States
Children's Mercy Kansas City
Kansas City, Missouri, United States
Primary Children's Hospital
Salt Lake City, Utah, United States